Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention

NCT00189124 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: Dehydroepiandrosterone (DHEA)

Sponsor

University of Michigan

Collaborators

[object Object]